Men’s Health just built a workout plan to stop a hidden side effect of weight loss drugs: muscle loss.
Quick Take
- Men’s Health released a four-week “GLP-1 Muscle Growth Plan” built for people on weight loss drugs like Ozempic, Wegovy, and Zepbound.
- The program calls for three training days a week with two to three working sets per exercise.
- Medical research backs the approach, showing resistance training and enough protein help protect muscle during drug-driven weight loss.
- Clinical trials on semaglutide and tirzepatide show real muscle loss happens, which is why experts push structured workouts, not just diet changes.
A Fitness Magazine Tackles A Real Side Effect
Men’s Health built its new four-week training plan because weight loss drugs do more than shrink fat. The magazine says it designed the “MH GLP-1 Muscle Growth Plan” with expert input to give users “a roadmap to keep your gains” while they lose weight on medication. The pitch is blunt: the drug alone will not protect your muscle. You have to train for it.
The plan itself is not vague advice to “move more.” It lays out three training days per week, with two to three working sets per movement, built to progress over the full month. That structure matters. Casual walking or light activity will not create enough stress on muscle tissue to protect it. Progressive resistance training does.
What The Research Actually Shows About Muscle Loss
This is not a marketing gimmick chasing a trend. Major obesity drug trials already flagged the muscle issue years ago. Estimates from the semaglutide and tirzepatide studies found a real share of total weight lost came from lean muscle, not just fat. That number worries doctors because muscle loss can slow metabolism and weaken older adults faster than fat loss ever would.
Medical researchers have landed on a consistent answer. Progressive resistance training, solid protein intake, and regular monitoring should go hand in hand with GLP-1 drug therapy, especially for patients at higher risk of losing strength and function. That is nearly the same formula Men’s Health built into its plan: structured lifting, done consistently, timed to match the drug’s effects on the body.
Why This Fits Into A Bigger Pattern
The research backs up what common sense already suggests. People who pair GLP-1 therapy with structured exercise hold onto more lean muscle than people who rely on the drug alone. That finding lines up across multiple studies, not just one. Diet and medication reduce the number on the scale. Only resistance training tells your body which tissue to keep and which to burn.
One broader review of weight loss pharmacology put it plainly: incretin drugs cause real lean mass loss, and resistance exercise is the key tool to fight it. That review was not written for a fitness magazine audience. It was written for doctors managing patients on these drugs long term. The overlap between clinical guidance and a mainstream workout plan says something important. This is not internet bro science. It is catching up to medicine.
The bigger lesson here extends past any one magazine program. Millions of Americans now take GLP-1 drugs, and many assume the injection does the heavy lifting on its own. It does not. These drugs suppress appetite and drive weight down fast, but they do not know the difference between fat and muscle. Without resistance training and enough protein, the body will often burn both. A structured plan like this one gives users a clear, doable path to protect strength while they lose weight, instead of leaving them to guess.
Sources:
menshealth.com, pmc.ncbi.nlm.nih.gov
